Cargando…

Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation

BACKGROUND: Angiopoietin-like proteins (ANGPTLs) 3 and 4 are circulating factors that participate in the regulation of lipid and glucose metabolism. SUBJECTS AND METHODS: We measured serum ANGPTL3 and 4 levels in 23 patients with obesity, 40 patients with obesity and type 2 diabetes mellitus (T2DM),...

Descripción completa

Detalles Bibliográficos
Autores principales: Cinkajzlová, Anna, Mráz, Miloš, Lacinová, Zdeňka, Kloučková, Jana, Kaválková, Petra, Kratochvílová, Helena, Trachta, Pavel, Křížová, Jarmila, Haluzíková, Denisa, Škrha, Jan, Papežová, Hana, Haluzík, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916880/
https://www.ncbi.nlm.nih.gov/pubmed/29695708
http://dx.doi.org/10.1038/s41387-018-0032-2
_version_ 1783317081324781568
author Cinkajzlová, Anna
Mráz, Miloš
Lacinová, Zdeňka
Kloučková, Jana
Kaválková, Petra
Kratochvílová, Helena
Trachta, Pavel
Křížová, Jarmila
Haluzíková, Denisa
Škrha, Jan
Papežová, Hana
Haluzík, Martin
author_facet Cinkajzlová, Anna
Mráz, Miloš
Lacinová, Zdeňka
Kloučková, Jana
Kaválková, Petra
Kratochvílová, Helena
Trachta, Pavel
Křížová, Jarmila
Haluzíková, Denisa
Škrha, Jan
Papežová, Hana
Haluzík, Martin
author_sort Cinkajzlová, Anna
collection PubMed
description BACKGROUND: Angiopoietin-like proteins (ANGPTLs) 3 and 4 are circulating factors that participate in the regulation of lipid and glucose metabolism. SUBJECTS AND METHODS: We measured serum ANGPTL3 and 4 levels in 23 patients with obesity, 40 patients with obesity and type 2 diabetes mellitus (T2DM), 22 patients with anorexia nervosa (AN), 15 subjects undergoing 72-h fasting, and 12 patients with short bowel syndrome (SBS), and their changes after very-low-calorie diet (VLCD), bariatric surgery, partial realimentation, acute fasting, and parenteral nutrition in order to assess their possible role in metabolic regulations. RESULTS: Serum ANGPTL4 levels were higher in obese subjects without/with T2DM (94.50 ± 9.51 and 134.19 ± 7.69 vs. 50.34 ± 4.22 ng/ml, p < 0.001) and lower in subjects with AN relative to healthy control subjects (38.22 ± 4.48 vs. 65.80 ± 7.98 ng/ml, p = 0.002), while serum ANGPTL3 levels demonstrated inverse tendency. Nutritional status had no effect on ANGPTL3 and 4 mRNA expression in adipose tissue. Fasting decreased ANGPTL3 and increased ANGPTL4 levels, while VLCD reduced only ANGPTL3. Bariatric surgery and realimentation of AN or SBS patients had no effect on either ANGPTL. Multiple regression analysis identified BMI as an independent predictor of ANGPTL3; and BMI and HbA(1c) as independent predictors of ANGPTL4, respectively. CONCLUSIONS: Taken together, our data suggest that serum ANGPTL3 and 4 levels are influenced by nutritional status and fasting and could be involved in the metabolic disturbances present in obesity and AN.
format Online
Article
Text
id pubmed-5916880
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59168802018-04-27 Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation Cinkajzlová, Anna Mráz, Miloš Lacinová, Zdeňka Kloučková, Jana Kaválková, Petra Kratochvílová, Helena Trachta, Pavel Křížová, Jarmila Haluzíková, Denisa Škrha, Jan Papežová, Hana Haluzík, Martin Nutr Diabetes Article BACKGROUND: Angiopoietin-like proteins (ANGPTLs) 3 and 4 are circulating factors that participate in the regulation of lipid and glucose metabolism. SUBJECTS AND METHODS: We measured serum ANGPTL3 and 4 levels in 23 patients with obesity, 40 patients with obesity and type 2 diabetes mellitus (T2DM), 22 patients with anorexia nervosa (AN), 15 subjects undergoing 72-h fasting, and 12 patients with short bowel syndrome (SBS), and their changes after very-low-calorie diet (VLCD), bariatric surgery, partial realimentation, acute fasting, and parenteral nutrition in order to assess their possible role in metabolic regulations. RESULTS: Serum ANGPTL4 levels were higher in obese subjects without/with T2DM (94.50 ± 9.51 and 134.19 ± 7.69 vs. 50.34 ± 4.22 ng/ml, p < 0.001) and lower in subjects with AN relative to healthy control subjects (38.22 ± 4.48 vs. 65.80 ± 7.98 ng/ml, p = 0.002), while serum ANGPTL3 levels demonstrated inverse tendency. Nutritional status had no effect on ANGPTL3 and 4 mRNA expression in adipose tissue. Fasting decreased ANGPTL3 and increased ANGPTL4 levels, while VLCD reduced only ANGPTL3. Bariatric surgery and realimentation of AN or SBS patients had no effect on either ANGPTL. Multiple regression analysis identified BMI as an independent predictor of ANGPTL3; and BMI and HbA(1c) as independent predictors of ANGPTL4, respectively. CONCLUSIONS: Taken together, our data suggest that serum ANGPTL3 and 4 levels are influenced by nutritional status and fasting and could be involved in the metabolic disturbances present in obesity and AN. Nature Publishing Group UK 2018-04-25 /pmc/articles/PMC5916880/ /pubmed/29695708 http://dx.doi.org/10.1038/s41387-018-0032-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Cinkajzlová, Anna
Mráz, Miloš
Lacinová, Zdeňka
Kloučková, Jana
Kaválková, Petra
Kratochvílová, Helena
Trachta, Pavel
Křížová, Jarmila
Haluzíková, Denisa
Škrha, Jan
Papežová, Hana
Haluzík, Martin
Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
title Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
title_full Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
title_fullStr Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
title_full_unstemmed Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
title_short Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
title_sort angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916880/
https://www.ncbi.nlm.nih.gov/pubmed/29695708
http://dx.doi.org/10.1038/s41387-018-0032-2
work_keys_str_mv AT cinkajzlovaanna angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT mrazmilos angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT lacinovazdenka angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT klouckovajana angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT kavalkovapetra angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT kratochvilovahelena angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT trachtapavel angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT krizovajarmila angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT haluzikovadenisa angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT skrhajan angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT papezovahana angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation
AT haluzikmartin angiopoietinlikeprotein3and4inobesitytype2diabetesmellitusandmalnutritiontheeffectofweightreductionandrealimentation